KRAIG BIOCRAFT LABORATORIES ORD SHS Overview
Latest P/E ratio for KRAIG BIOCRAFT LABORATORIES ORD SHS: -21.05 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-21.05
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for KBLB is -21.05. That is below the sector sector average of 27.12. Investors often review this figure alongside KRAIG BIOCRAFT LABORATORIES ORD SHS's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, KBLB currently prints -21.05 for P/E ratio, while the sector average sits near 27.12. That is roughly 177.6% below the sector mean. Large gaps often invite a closer look at KRAIG BIOCRAFT LABORATORIES ORD SHS's growth, margins, and balance sheet.
A P/E ratio of -21.05 for KRAIG BIOCRAFT LABORATORIES ORD SHS is not 'good' or 'bad' on its own. Compare it with the peer average (27.12) and with KBLB's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting KBLB's P/E ratio (-21.05), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
